| 13 |
Hanall Biopharma, Launching “Fordream Tab,” Tadalafil-containing Impotence Drug
|
2015-09-04 |
admin |
1836 |
| 12 |
Hanall, Boosting the R&D of New Global Medicine through Joint Management with Daewoong Pharmaceutical
|
2015-06-01 |
admin |
2167 |
| 11 |
Hanall Biopharm, Exporting New Diabetic Medicine “Glucodown Tab OR” to Iran
|
2015-03-09 |
admin |
1957 |
| 10 |
Hanall Biopharma, Conclusion of MOU for Korea Drug Development Fund Project of New Antibody Medicine against Autoimmunity Disease
|
2015-02-26 |
admin |
1261 |
| 9 |
Hanall Biopharma, Applied the Clinical Trial Phase 1 for New Medicine of Dry Eye Diseases
|
2015-02-23 |
admin |
1091 |
| 8 |
Hanall, Sponsoring Daily Supplies worth 17 million KRW for the neglected in pain of xerosis
|
2015-01-07 |
admin |
1147 |
| 7 |
Hanall Biopharma, Sponsoring Medicines worth 82 million KRW to Community Chest of Korea
|
2015-01-07 |
admin |
1051 |
| 6 |
Hanall Biopharma Received the “2014 Grand Prize of King Sejong Voluntary Service of Sharing”
|
2014-12-09 |
admin |
943 |
| 5 |
Hanall is Entering into the 60 Billion KRW Market with Peptic Ulcer Drug “Wibis Tab”
|
2014-12-01 |
admin |
1222 |
| 4 |
Hanall Biopharma, Achieving Surplus for Three Consecutive Quarters
|
2014-11-21 |
admin |
1010 |